Ceramide dissociates 3′-phosphoinositide production from pleckstrin homology domain translocation
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Numerous hormones, cytokines and transforming oncogenes activate phosphoinositide 3-kinase (PI-3K), a lipid kinase that initiates signal transduction cascades regulating cellular proliferation, survival, protein synthesis and glucose metabolism. PI-3K catalyses the production of the 3'-phosphoinositides PtdIns(3,4)P(2) and PtdIns(3,4,5)P(3), which recruit downstream effector enzymes to the membrane via their pleckstrin homology (PH) domains. Recent studies have indicated that another signalling lipid, the sphingolipid ceramide, inhibits several PI-3K-dependent events, including insulin-stimulated glucose uptake and growth-factor-stimulated cell survival. Here we show that ceramide analogues specifically prevent the recruitment of the PtdIns(3,4,5)P(3)-binding proteins Akt/protein kinase B (PKB) or the general receptor for phosphoinositides-1 (GRP1). Specifically, the short-chain ceramide derivative C2-ceramide inhibited the platelet-derived growth factor (PDGF)-stimulated translocation of full-length Akt/PKB, as well as truncated proteins encoding only the PH domains of Akt/PKB or GRP1. C2-ceramide did not alter the membrane localization of the PH domain for phospholipase Cdelta, which preferentially binds PtdIns(4,5)P(2), nor did it affect the PDGF-stimulated production of PtdIns(3,4)P(2) or PtdIns(3,4,5)P(3). Interestingly, a glucosylceramide synthase inhibitor, 1-phenyl-2-decanoylamino-3-morpholinopropan-1-ol (PDMP), shown previously to increase intracellular ceramide concentrations without affecting PI-3K [Rani, Abe, Chang, Rosenzweig, Saltiel, Radin and Shayman (1995) J. Biol. Chem. 270, 2859-2867], recapitulated the inhibitory effects of C2-ceramide on PDGF-stimulated Akt/PKB phosphorylation. These studies indicate that ceramide prevents the translocation of certain PtdIns(3,4,5)P(3)-binding proteins, despite the presence of a full complement of PtdIns(3,4)P(2) or PtdIns(3,4,5)P(3). Furthermore, these findings suggest a mechanism by which stimuli that induce ceramide synthesis could negate the fundamental signalling pathways initiated by PI-3K.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In particular, an overabundance of SFA (e.g., Palmitate) can induce IR through the accumulation of lipid derivatives including DAGs, ceramides and long chain acyl-CoAs in the cytosol, which in turn can interfere with IRS1-PKB signalling [113,114,115,116,117,118].”
From Omega-3 Fatty Acids and Skeletal Muscle Health (2015) · cites this paper as [114]
In the citing paper
“Ceramide can also attenuate insulin signaling through its ability to inhibit Akt/PKB (63).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [63]
Citations
Cites
Cellular survival: a play in three Akts
Datta, S. R., Brunet, A., & Greenberg, M. E. (1999) · Genes & Development · doi:10.1101/gad.13.22.2905 · Cited by 4,216
Maehama, T., & Dixon, J. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13375 · Cited by 3,104
Alessi, D. R., James, S. R., Downes, C. P., Holmes, A. B., Gaffney, P. R. J., Reese, C. B., & Cohen, P. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00122-9 · Cited by 2,826
Requirement for Phosphatidylinositol-3 Kinase in the Prevention of Apoptosis by Nerve Growth Factor
Yao, R., & Cooper, G. M. (1995) · Science · doi:10.1126/science.7701324 · Cited by 1,391
The sphingomyelin cycle and the second messenger function of ceramide.
Hannun, Y. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41834-5 · Cited by 1,235
Fatty acid-induced β cell apoptosis: A link between obesity and diabetes
Shimabukuro, M., Zhou, Y.-T., Levi, M., & Unger, R. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2498 · Cited by 1,142
Delcommenne, M., Tan, C., Gray, V., Rue, L., Woodgett, J., & Dedhar, S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.19.11211 · Cited by 1,092
Várnai, P., & Balla, T. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.143.2.501 · Cited by 859
Phosphorylation and Activation of p70 s6k by PDK1
Pullen, N., Dennis, P. B., Andjelkovic, M., Dufner, A., Kozma, S. C., Hemmings, B. A., & Thomas, G. (1998) · Science · doi:10.1126/science.279.5351.707 · Cited by 826
Santana, P., Peña, L. A., Haimovitz-Friedman, A., Martin, S., Green, D., McLoughlin, M., Cordon-Cardo, C., Schuchman, E. H., Fuks, Z., & Kolesnick, R. (1996) · Cell · doi:10.1016/s0092-8674(00)80091-4 · Cited by 797
Cited by
Mechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028
Holland, W. L., Brozinick, J. T., Wang, L.-P., Hawkins, E. D., Sargent, K. M., Liu, Y., Narra, K., Hoehn, K. L., Knotts, T. A., Siesky, A., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.01.002 · Cited by 1,232
Self-citationInsulin sensitivity: Modulation by nutrients and inflammation
Schenk, S., Saberi, M., & Olefsky, J. M. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34260 · Cited by 1,191
Ceramides in insulin resistance and lipotoxicity
SUMMERS, S. (2006) · Progress in Lipid Research · doi:10.1016/j.plipres.2005.11.002 · Cited by 848
Self-citationCeramide in apoptosis: an overview and current perspectives
Pettus, B. J., Chalfant, C. E., & Hannun, Y. A. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(02)00331-1 · Cited by 788
A Ceramide-Centric View of Insulin Resistance
Chavez, J. A., & Summers, S. A. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.002 · Cited by 610
Self-citationHolland, W. L., & Summers, S. A. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0025 · Cited by 595
Self-citationFleishman, J. S., & Kumar, S. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01811-6 · Cited by 544
Chavez, J. A., & Summers, S. A. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.08.020 · Cited by 498
Self-citationCeramide: second messenger or modulator of membrane structure and dynamics?
BLITTERSWIJK, W. J. V., LUIT, A. H. V. D., VELDMAN, R. J., VERHEIJ, M., & BORST, J. (2003) · Biochemical Journal · doi:10.1042/bj20021528 · Cited by 435
Sphingolipids and phospholipids in insulin resistance and related metabolic disorders
Meikle, P. J., & Summers, S. A. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.169 · Cited by 423
Self-citationCeramides as modulators of cellular and whole-body metabolism
Bikman, B. T., & Summers, S. A. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57144 · Cited by 419
Self-citationRegulation of Insulin Action by Ceramide
Stratford, S., Hoehn, K. L., Liu, F., & Summers, S. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406499200 · Cited by 410
Self-citationSwanton, C., Marani, M., Pardo, O., Warne, P. H., Kelly, G., Sahai, E., Elustondo, F., Chang, J., Temple, J., Ahmed, A. A., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.04.011 · Cited by 381
Powell, D. J., Hajduch, E., Kular, G., & Hundal, H. S. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.21.7794-7808.2003 · Cited by 370
Sergi, D., Naumovski, N., Heilbronn, L. K., Abeywardena, M., O’Callaghan, N., Lionetti, L., & Luscombe-Marsh, N. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00532 · Cited by 347
Wang, D. D., Toledo, E., Hruby, A., Rosner, B. A., Willett, W. C., Sun, Q., Razquin, C., Zheng, Y., Ruiz-Canela, M., Guasch-Ferré, M., et al. (2017) · Circulation · doi:10.1161/circulationaha.116.024261 · Cited by 327
(n-3) Fatty Acids Alleviate Adipose Tissue Inflammation and Insulin Resistance: Mechanistic Insights
Kalupahana, N. S., Claycombe, K. J., & Moustaid-Moussa, N. (2011) · Advances in Nutrition · doi:10.3945/an.111.000505 · Cited by 305
“Awell-studied example is inhibition by Akt of the forkhead box O-mediated activation of hepatic gluconeogenic genes in the liver (64).”
InfluentialSphingolipids in mammalian cell signalling
Ohanian, J., & Ohanian, V. (2001) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000836 · Cited by 283
Zhang, L., Keung, W., Samokhvalov, V., Wang, W., & Lopaschuk, G. D. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.09.014 · Cited by 257
Immunity as a link between obesity and insulin resistance
Kalupahana, N. S., Moustaid-Moussa, N., & Claycombe, K. J. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2011.10.011 · Cited by 253
Protein Kinase B/Akt Prevents Fatty Acid-induced Apoptosis in Pancreatic β-Cells (INS-1)
Wrede, C. E., Dickson, L. M., Lingohr, M. K., Briaud, I., & Rhodes, C. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208756200 · Cited by 246
Sphingolipid Signaling in Metabolic Disorders
Hla, T., & Dannenberg, A. J. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.06.017 · Cited by 246
Ectopic lipid storage and insulin resistance: a harmful relationship
Borén, J., Taskinen, M. ‐., Olofsson, S. ‐., & Levin, M. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12071 · Cited by 234
Law, B. A., Liao, X., Moore, K. S., Southard, A., Roddy, P., Ji, R., Szulc, Z., Bielawska, A., Schulze, P. C., & Cowart, L. A. (2018) · The FASEB Journal · doi:10.1096/fj.201700300r · Cited by 221
Omega-3 Fatty Acids and Skeletal Muscle Health
Jeromson, S., Gallagher, I., Galloway, S., & Hamilton, D. (2015) · Marine Drugs · doi:10.3390/md13116977 · Cited by 203
Role of ceramide in diabetes mellitus: evidence and mechanisms
Galadari, S., Rahman, A., Pallichankandy, S., Galadari, A., & Thayyullathil, F. (2013) · Lipids in Health and Disease · doi:10.1186/1476-511x-12-98 · Cited by 195
Reducing Plasma Membrane Sphingomyelin Increases Insulin Sensitivity
Li, Z., Zhang, H., Liu, J., Liang, C.-P., Li, Y., Li, Y., Teitelman, G., Beyer, T., Bui, H. H., Peake, D. A., et al. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05893-11 · Cited by 188
Summers, S. A., & Nelson, D. H. (2005) · Diabetes · doi:10.2337/diabetes.54.3.591 · Cited by 185
Self-citationDenlinger, L. C., Fisette, P. L., Sommer, J. A., Watters, J. J., Prabhu, U., Dubyak, G. R., Proctor, R. A., & Bertics, P. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.4.1871 · Cited by 181
Pancreatic β-cell growth and survival – a role in obesity-linked type 2 diabetes?
Lingohr, M. K., Buettner, R., & Rhodes, C. J. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02377-8 · Cited by 168
Ellert-Miklaszewska, A., Kaminska, B., & Konarska, L. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2004.05.011 · Cited by 165
Food Polyphenols and Type II Diabetes Mellitus: Pharmacology and Mechanisms
Naz, R., Saqib, F., Awadallah, S., Wahid, M., Latif, M. F., Iqbal, I., & Mubarak, M. S. (2023) · Molecules · doi:10.3390/molecules28103996 · Cited by 163
Várnai, P., Bondeva, T., Tamás, P., Tóth, B. I., Buday, L., Hunyady, L., & Balla, T. (2005) · Journal of Cell Science · doi:10.1242/jcs.02606 · Cited by 163
Obesity: A Review of Pathophysiology and Classification
Busebee, B., Ghusn, W., Cifuentes, L., & Acosta, A. (2023) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2023.05.026 · Cited by 159
Dickson, L. M., & Rhodes, C. J. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00031.2004 · Cited by 159
Cazzolli, R., Carpenter, L., Biden, T. J., & Schmitz-Peiffer, C. (2001) · Diabetes · doi:10.2337/diabetes.50.10.2210 · Cited by 158
Sphingolipids and glycerophospholipids – The “ying and yang” of lipotoxicity in metabolic diseases
Rodriguez-Cuenca, S., Pellegrinelli, V., Campbell, M., Oresic, M., & Vidal-Puig, A. (2017) · Progress in Lipid Research · doi:10.1016/j.plipres.2017.01.002 · Cited by 152
Pathophysiology of type 2 diabetes and the impact of altered metabolic interorgan crosstalk
Sanches, J. M., Zhao, L. N., Salehi, A. A., Wollheim, C. B., & Kaldis, P. (2021) · FEBS Journal · doi:10.1111/febs.16306 · Cited by 151
Mediators of cytokine-induced insulin resistance in obesity and other inflammatory settings
Marette, A. (2002) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/00075197-200207000-00005 · Cited by 149
Gosejacob, D., Jäger, P. S., Dorp, K. V., Frejno, M., Carstensen, A., Köhnke, M., Degen, J., Dörmann, P., & Hoch, M. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.691212 · Cited by 142
Ceramides and mitochondrial fatty acid oxidation in obesity
Fucho, R., Casals, N., Serra, D., & Herrero, L. (2016) · The FASEB Journal · doi:10.1096/fj.201601156r · Cited by 137
Sphingolipids and insulin resistance: the five Ws
Summers, S. A. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283373b66 · Cited by 136
Self-citationHajduch, É., Turban, S., Lièpvre, X. L., Lay, S. L., Lipina, C., Dimopoulos, N., Dugail, I., & Hundal, H. S. (2008) · Biochemical Journal · doi:10.1042/bj20070936 · Cited by 132
Fatty Heart, Cardiac Damage, and Inflammation
Guzzardi, M. A., & Iozzo, P. (2011) · The Review of Diabetic Studies · doi:10.1900/rds.2011.8.403 · Cited by 128
Sphingomyelin and Its Role in Cellular Signaling
Chakraborty, M., & Jiang, X. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-6331-9_1 · Cited by 123
Role of ceramides in the pathogenesis of diabetes mellitus and its complications
Mandal, N. A., Grambergs, R. C., Mondal, K., Basu, S. K., Tahia, F., & Dagogo-Jack, S. E. (2020) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2020.107734 · Cited by 117
Non-alcoholic fatty liver disease and insulin resistance: From bench to bedside
Gariani, K., Philippe, J., & Jornayvaz, F. R. (2013) · Diabetes & Metabolism · doi:10.1016/j.diabet.2012.11.002 · Cited by 113
Novel Insights and Mechanisms of Lipotoxicity-Driven Insulin Resistance
Lair, B., Laurens, C., Bosch, B. V. D., & Moro, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176358 · Cited by 107
Adipocyte Ceramides—The Nexus of Inflammation and Metabolic Disease
Chaurasia, B., Talbot, C. L., & Summers, S. A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.576347 · Cited by 106
Self-citationHigh fat diet induced diabetic cardiomyopathy
Dirkx, E., Schwenk, R. W., Glatz, J. F. C., Luiken, J. J. F. P., & van Eys, G. J. J. M. (2011) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2011.04.018 · Cited by 104
Membrane lipid alterations in the metabolic syndrome and the role of dietary oils
Perona, J. S. (2017) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2017.04.015 · Cited by 98
Chang, X., Wang, Z., Zhang, J., Yan, H., Bian, H., Xia, M., Lin, H., Jiang, J., & Gao, X. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-0982-x · Cited by 96
Sphingolipid metabolism in non-alcoholic fatty liver diseases
Régnier, M., Polizzi, A., Guillou, H., & Loiseau, N. (2018) · Biochimie · doi:10.1016/j.biochi.2018.07.021 · Cited by 95
Watson, M. L., Coghlan, M., & Hundal, H. S. (2009) · Biochemical Journal · doi:10.1042/bj20081149 · Cited by 93
Siddique, M. M., Li, Y., Wang, L., Ching, J., Mal, M., Ilkayeva, O., Wu, Y., Bay, B., & Summers, S. A. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00226-13 · Cited by 91
Self-citationMielke, M. M., Bandaru, V. V. R., Han, D., An, Y., Resnick, S. M., Ferrucci, L., & Haughey, N. J. (2015) · Aging Cell · doi:10.1111/acel.12369 · Cited by 91
Mitochondrial fission mediates ceramide-induced metabolic disruption in skeletal muscle
Smith, M. E., Tippetts, T. S., Brassfield, E. S., Tucker, B. J., Ockey, A., Swensen, A. C., Anthonymuthu, T. S., Washburn, T. D., Kane, D. A., Prince, J. T., et al. (2013) · Biochemical Journal · doi:10.1042/bj20130807 · Cited by 87
Barsacchi, R., Perrotta, C., Bulotta, S., Moncada, S., Borgese, N., & Clementi, E. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.4.886 · Cited by 87
Sphingolipids: agents provocateurs in the pathogenesis of insulin resistance
Lipina, C., & Hundal, H. S. (2011) · Diabetologia · doi:10.1007/s00125-011-2127-3 · Cited by 83
“Since initial work demonstrated that ceramide does not directly interact with PKB or inhibit upstream signalling events such as the activation of phosphoinositide 3-kinase by hormonal stimuli [19, 20, 45], researchers undertook alternative approaches in an attempt to explain its suppressive effect.”
BackgroundA Monoclonal Antibody to Visualize PtdIns(3,4,5)P 3 in Cells
Chen, R., Kang, V. H., Chen, J., Shope, J. C., Torabinejad, J., DeWald, D. B., & Prestwich, G. D. (2002) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540205000511 · Cited by 78
Self-citationLingohr, M. K., Dickson, L. M., Wrede, C. E., Briaud, I., McCuaig, J. F., Myers, M. G., & Rhodes, C. J. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.08.003 · Cited by 78
Park, M., Kaddai, V., Ching, J., Fridianto, K. T., Sieli, R. J., Sugii, S., & Summers, S. A. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.737684 · Cited by 77
Self-citationMetformin limits ceramide-induced senescence in C2C12 myoblasts
Jadhav, K. S., Dungan, C. M., & Williamson, D. L. (2013) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2013.11.002 · Cited by 72
Machacek, M. E., Saunders, H. I., Zhang, Z., Tan, E. P., Li, J., Li, T., Villar, M. T., Artigues, A., Lydic, T. A., Cork, G. K., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.008373 · Cited by 71
Adipose Tissue and Ceramide Biosynthesis in the Pathogenesis of Obesity
Samad, F., Badeanlou, L., Shah, C., & Yang, G. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0650-1_5 · Cited by 70
Li, Y., Talbot, C. L., & Chaurasia, B. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00407 · Cited by 69
Ceramides are fuel gauges on the drive to cardiometabolic disease
Wilkerson, J. L., Tatum, S. M., Holland, W. L., & Summers, S. A. (2024) · Physiological Reviews · doi:10.1152/physrev.00008.2023 · Cited by 67
Self-citationGPRC5B-Mediated Sphingomyelin Synthase 2 Phosphorylation Plays a Critical Role in Insulin Resistance
Kim, Y., Greimel, P., & Hirabayashi, Y. (2018) · iScience · doi:10.1016/j.isci.2018.10.001 · Cited by 67
Kaneko, Y., Kitazato, K., & Basaki, Y. (2003) · Journal of Cell Science · doi:10.1242/jcs.00871 · Cited by 67
Osawa, Y., Seki, E., Kodama, Y., Suetsugu, A., Miura, K., Adachi, M., Ito, H., Shiratori, Y., Banno, Y., Olefsky, J. M., et al. (2010) · The FASEB Journal · doi:10.1096/fj.10-168351 · Cited by 62
RIBAUX, P. G., & IYNEDJIAN, P. B. (2003) · Biochemical Journal · doi:10.1042/bj20031287 · Cited by 61
“Actin”g on GLUT4: Membrane & Cytoskeletal Components of Insulin Action
Brozinick, J. T., Berkemeier, B., & Elmendorf, J. S. (2007) · Current Diabetes Reviews · doi:10.2174/157339907780598199 · Cited by 60
Wrede, C., Dickson, L., Lingohr, M. K., Briaud, I., & Rhodes, C. J. (2003) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0300271 · Cited by 59
Ceramide inhibits LPS‐induced production of IL‐5, IL‐10, and IL‐13 from mast cells
Chiba, N., Masuda, A., Yoshikai, Y., & Matsuguchi, T. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21101 · Cited by 59
Chiu, T. T., Sun, Y., Koshkina, A., & Klip, A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.467647 · Cited by 58
The regulation of glucose and lipid homeostasis via PLTP as a mediator of BAT–liver communication
Sponton, C. H., Hosono, T., Taura, J., Jedrychowski, M. P., Yoneshiro, T., Wang, Q., Takahashi, M., Matsui, Y., Ikeda, K., Oguri, Y., et al. (2020) · EMBO Reports · doi:10.15252/embr.201949828 · Cited by 57
Rotten to the Cortex: Ceramide-Mediated Lipotoxicity in Diabetic Kidney Disease
Nicholson, R. J., Pezzolesi, M. G., & Summers, S. A. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.622692 · Cited by 56
Self-citationDefective Akt activation is associated with glucose- but not glucosamine-induced insulin resistance
Nelson, B., Robinson, K. A., & Buse, M. G. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00438.2001 · Cited by 54
Phosphorylation of cardiac protein kinase B is regulated by palmitate
Soltys, C.-L. M., Buchholz, L., Gandhi, M., Clanachan, A. S., Walsh, K., & Dyck, J. R. B. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00275.2002 · Cited by 54
Castillo, R. I., Rojo, L. E., Henriquez-Henriquez, M., Silva, H., Maturana, A., Villar, M. J., Fuentes, M., & Gaspar, P. A. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00488 · Cited by 51
Obesity-Related Insulin Resistance: The Central Role of Adipose Tissue Dysfunction
Mocciaro, G., & Gastaldelli, A. (2022) · Handbook of experimental pharmacology · doi:10.1007/164_2021_573 · Cited by 48
Role of ceramide in apoptosis and development of insulin resistance
Kuzmenko, D. I., & Klimenteva, T. K. (2016) · Biochemistry (Moscow) · doi:10.1134/s0006297916090017 · Cited by 48
Macrophage Rewiring by Nutrient Associated PI3K Dependent Pathways
Sharif, O., Brunner, J. S., Vogel, A., & Schabbauer, G. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02002 · Cited by 47
New role for ceramide in hypoxia and insulin resistance
Xia, Q., Lu, F., Wu, F., Huang, Z., Dong, H., Xu, L., & Gong, J. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i18.2177 · Cited by 44
Ceramides: Nutrient Signals that Drive Hepatosteatosis
Summers, S. A. (2020) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2020.9.1.50 · Cited by 43
Self-citationDefining lipid mediators of insulin resistance: controversies and challenges
Metcalfe, L. K., Smith, G. C., & Turner, N. A. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0023 · Cited by 41
The protective role of liver X receptor (LXR) during fumonisin B1-induced hepatotoxicity
Régnier, M., Polizzi, A., Lukowicz, C., Smati, S., Lasserre, F., Lippi, Y., Naylies, C., Laffitte, J., Bétoulières, C., Montagner, A., et al. (2018) · Archives of Toxicology · doi:10.1007/s00204-018-2345-2 · Cited by 41
Kurek, K., Wiesiołek‐Kurek, P., Ziembicka, D., Łukaszuk, B., Chabowski, A., & Żendzian‐Piotrowska, M. (2014) · BioMed Research International · doi:10.1155/2014/980815 · Cited by 41
Translational Aspects of Sphingolipid Metabolism in Renal Disorders
Daher, A. A., Jalkh, T. E., Eid, A. A., Fornoni, A., Marples, B., & Zeidan, Y. H. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122528 · Cited by 41
Phosphoinositide 3-kinase inhibition in cancer treatment
Berrie, C. P. (2001) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.10.6.1085 · Cited by 41
Imierska, M., Kurianiuk, A., & Błachnio-Zabielska, A. (2020) · Biomolecules · doi:10.3390/biom10121665 · Cited by 39
Lin, S., Chen, R., Chen, Y., Chiang, W., Tsai, T., & Hsieh, B. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.4.811 · Cited by 38
Molecular mechanism of lipid-induced cardiac insulin resistance and contractile dysfunction
Liu, Y., Neumann, D., Glatz, J. F. C., & Luiken, J. J. F. P. (2016) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2016.06.002 · Cited by 38
Thors, B., Halldórsson, H., Clarke, G. D., & Þorgeirsson, G. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00127-8 · Cited by 36
Robinson, K. A., & Buse, M. G. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00644.2007 · Cited by 34
Kralik, S. F., Liu, P., Leffler, B. J., & Elmendorf, J. S. (2002) · Endocrinology · doi:10.1210/en.143.1.37 · Cited by 33
Juszczyk, A., Jankowska, K., Zawiślak, B., Surdacki, A., & Chyrchel, B. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9092681 · Cited by 32
Adiponectin and its Hydrolase-Activated Receptors.
Sharma, A. X., & Holland, W. L. (2017) · PubMed · Cited by 30
Foley, K. P., & Klip, A. (2014) · Biology Open · doi:10.1242/bio.20147898 · Cited by 28
Metadata
- Authors
- STRATFORD, S., DEWALD, D. B., & SUMMERS, S. A.
- Affiliations
- Colorado State University (US)
- Utah State University (US)
- Corresponding author
- STRATFORD, Suzanne
- ORCID
- SUMMERS, Scott A.
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 2001-02-22
- Volume
- 354
- Issue
- 2
- Pages
- 359-368
- ISSN
- 0264-6021 (ISSN-L)
- 1470-8728
- PMC
- PMC1221664
- OpenAlex
- W2051970831
- Cited by
- 161
- References
- 53
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 4 · 2023: 5 · 2022: 3 · 2021: 3 · 2020: 10 · 2019: 4 · 2018: 10 · 2017: 9 · 2016: 13 · 2015: 8 · 2014: 6 · 2013: 8 · 2012: 5
- FWCI
- 3.48
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Biochemical Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- ceramide, phosphatidylinositol 3-kinase, phosphatidylinositol 3,4,5-trisphosphate, pleckstrin homology domain, Akt/protein kinase B, GRP1, PDGF signaling, membrane translocation, glucosylceramide synthase, prescription drug monitoring programs, PtdIns(3,4)P2, phosphoinositide signaling
- MeSH terms
- Animals, Blood Proteins, Ceramides, Dose-Response Relationship, Drug, Fluorescent Antibody Technique, Isoenzymes, Monosaccharide Transport Proteins, Muscle Proteins, Phosphatidylinositols, Type C Phospholipases, Phosphoproteins, Phosphorylation, Platelet-Derived Growth Factor, Proto-Oncogene Proteins, Sphingolipids, Sphingosine, Structure-Activity Relationship, 3T3 Cells, Protein Serine-Threonine Kinases, Sequence Homology, Amino Acid, Phosphatidylinositol Phosphates, Phosphatidylinositol 3-Kinases, Proto-Oncogene Proteins c-akt, Glucose Transporter Type 4, Mice, Phospholipase C delta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.